Skip to Main Content

Author Details

Fritz C Eilber
University of California, Los Angeles David Geffen School of Medicine
1999
132
41
PMIDPaper TitleJournal TitlePublished Year
36690841ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
37760460IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.Cancers (Basel)2023
37292676The landscape of drug sensitivity and resistance in sarcoma.bioRxiv2023
37057834Does "Low-Grade" Dedifferentiated Liposarcoma Exist? The Role of Mitotic Index in Separating Dedifferentiated Liposarcoma From Cellular Well-differentiated Liposarcoma.Am J Surg Pathol2023
37146173FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature Cells.Clin Nucl Med2023
37333052Fibroblast Activation Protein Expression in Sarcomas.Sarcoma2023
36581724Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
36581724Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
36690841ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
34593596<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma.J Nucl Med2022
34407970A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors.Clin Cancer Res2022
34546387High <sup>68</sup> Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma.Eur J Nucl Med Mol Imaging2022
33400014Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies.Curr Treat Options Oncol2021
33908045Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation.Med Phys2021
34720663Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma.Sarcoma2021
32755981Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database Analysis.J Natl Compr Canc Netw2020
32054730A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.Clin Cancer Res2020
33063147[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial.EJNMMI Res2020
32846908Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma.Cancers (Basel)2020
30616082The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.Biomed Pharmacother2019
31687646Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases.JBMR Plus2019
30024282Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models.J Drug Target2019
31436746Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.Am J Clin Oncol2019
30913092Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.Am J Clin Oncol2019
28681998Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.J Cell Biochem2018
30166061Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.Biochem Biophys Res Commun2018
30126369Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.BMC Cancer2018
29932244Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.J Cell Biochem2018
29958690Corrigendum to "Pericytic mimicry in well-differentiated liposarcoma/atypical lipomatous tumor" (Hum Pathol 2016;54:92-99).Hum Pathol2018
30060824Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.Tissue Cell2018
30003151Tumor-targeting <i>Salmonella typhimurium</i> A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations.Heliyon2018
30292411A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model.Biochem Biophys Res Commun2018
30392912Metabolic targeting with recombinant methioninase combined with palbociclib regresses a doxorubicin-resistant dedifferentiated liposarcoma.Biochem Biophys Res Commun2018
30673664Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model.Chemotherapy2018
30309504Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP).Tissue Cell2018
30275182Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model.Anticancer Res2018
29384032Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Cell Cycle2018
29721200Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Oncotarget2018
29664796Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.Am J Clin Oncol2018
29541401Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.Oncotarget2018
29713497Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting <i>S. typhimurium</i> A1-R is superior to first-line chemotherapy.Signal Transduct Target Ther2018
29374999Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.Cell Cycle2018
29737543Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy.J Cell Biochem2018
29481803Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models.Biochem Biophys Res Commun2018
29334307Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Cell Cycle2018
29306021Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma.Cancer Lett2018
29081066Long-term outcomes of cement in cement technique for revision endoprosthesis surgery.J Surg Oncol2018
29220297Local Control of Soft Tissue and Bone Sarcomas.J Clin Oncol2018
29143983Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase.J Cell Biochem2018
29187018Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.Cell Cycle2018
  • 1 - 50 of 132

Recommended Authors

Saskia Liti??re
Center for Statistics, Hasselt University
Career Start Year 2007
Number of shared co-authors 0
Kjetil Boye
Oslo University Hospital
Career Start Year 2007
Number of shared co-authors 1
Wendong Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Christian F Meyer
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 3
Joseph A Ludwig
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Bernadette Liegl-Atzwanger
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 3
Sandra J Strauss
University College London, Cancer Institute
Career Start Year 2003
Number of shared co-authors 1
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Carol D Morris
The Johns Hopkins Hospital
Career Start Year 2001
Number of shared co-authors 3
Sung Wook Seo
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
Elizabeth G Demicco
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 2000
Number of shared co-authors 2
Jilong Yang
Tianjin Medical University Cancer Institute and Hospital
Career Start Year 2000
Number of shared co-authors 1
Angela C Hirbe
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Najat C Daw
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Career Start Year 1995
Number of shared co-authors 4
Richard Gorlick
University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Rebecca A Gladdy
Mount Sinai Hospital
Career Start Year 1994
Number of shared co-authors 2
Uta Dirksen
University Hospital Essen, West German Cancer Center
Career Start Year 1994
Number of shared co-authors 1
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 4
John M Kane
Roswell Park Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 3
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 1
Jeremy Whelan
University College London Hospitals NHS Foundation Trust
Career Start Year 1991
Number of shared co-authors 0
Jay S Wunder
University of Toronto
Career Start Year 1990
Number of shared co-authors 4
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 5
Ivy A Petersen
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 2
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 1
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 3
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 2
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Career Start Year 1979
Number of shared co-authors 4

Collaborators

Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 73
Scott D Nelson
University of California-Los Angeles
Co-authored papers 72
Arun S Singh
University of California-Los Angeles
Co-authored papers 65
Robert M Hoffman
Co-authored papers 52
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers 28
Frederick R Eilber
University of California-Los Angeles
Co-authored papers 23
Noah Federman
University of California los angeles
Co-authored papers 20
Nicholas M Bernthal
University of California-Los Angeles
Co-authored papers 18
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers 13
Johannes Czernin
university of california los angeles
Co-authored papers 13
Joseph G Crompton
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 12
Michael Bouvet
Co-authored papers 9
Jane Yanagawa
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 7
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 6
Susan V Bukata
University of California
Co-authored papers 5
Jeremie Calais
university of california los angeles
Co-authored papers 5
Michael L Steinberg
University of California los angeles
Co-authored papers 5
Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers 4
Robert B Cameron
University of California los angeles
Co-authored papers 3
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers 3
Yingli Yang
Ruijin Hospital
Co-authored papers 2
Heather R Christofk
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 2
Dan Ruan
Zhongshan Hospital, Fudan University
Co-authored papers 2
Jomjit Chantharasamee
Siriraj Hospital, Mahidol University
Co-authored papers 2
Thinzar M Lwin
City of Hope National Medical Center
Co-authored papers 2
Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers 1
Yu Gao
University of California los angeles
Co-authored papers 1
Nasrin Tavanaie
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Owen N Witte
University of California los angeles
Co-authored papers 1
Francis J Hornicek
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 1
Release 1.2